J&J Medical Connect
Janssen COVID-19 Vaccine

(Ad26.COV2.S)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

Janssen COVID-19 Vaccine (Ad26.COV2.S)

Patient Medical Information

+ Save link

Discontinuation and EUA Withdrawal

Last Updated: 05/30/2025

SUMMARY  

  • On May 22, 2023, Johnson and Johnson requested the voluntary withdrawal of the emergency use authorization (EUA) of the Janssen COVID-19 Vaccine. On June 1, 2023, the Food and Drug Administration (FDA) revoked the EUA for this vaccine.1
  • The last lots of the vaccine purchased by the United States (U.S.) Government expired on May 13, 2023.   
  • The discontinuation and EUA withdrawal are not associated with concerns about the quality or safety of the Janssen COVID-19 Vaccine.
  • Any unused COVID-19 vaccine or waste material should be disposed in compliance with local guidance.
  • For additional information, please visit https://www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber-regulated-biologics/janssen-covid-19-vaccine.

 

References

Show
1 Food and Drug Administration. Janssen COVID-19 Vaccine. Accessed 27 May 2025. Available at: https://www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber-regulated-biologics/janssen-covid-19-vaccine